Cargando…

Bioinformatics approach reveals the key role of C-X-C motif chemokine receptor 2 in endometriosis development

Endometriosis is a common gynecological disease, affecting 6–10% of women of reproductive age. The precise mechanisms underlying the development of endometriosis remain unclear. In the present study, a bioinformatics approach was applied to systematically identify the pathways and genes involved in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Aili, Luo, Ruoyu, Liang, Hua, Li, Mengru, Ruan, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102705/ https://www.ncbi.nlm.nih.gov/pubmed/30015967 http://dx.doi.org/10.3892/mmr.2018.9275

Ejemplares similares

Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer
por: Sun, Jiping, et al.
Publicado: (2022)

Impacts of Chemokine (C-X-C Motif) Receptor 2 C1208T Polymorphism on Cancer Susceptibility
por: Zhou, Jing, et al.
Publicado: (2021)

Receptor‐Interacting Protein Kinase 3 Deficiency Recruits Myeloid‐Derived Suppressor Cells to Hepatocellular Carcinoma Through the Chemokine (C‐X‐C Motif) Ligand 1–Chemokine (C‐X‐C Motif) Receptor 2 Axis
por: Li, Yi‐Ming, et al.
Publicado: (2019)

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment
por: Wani, Nissar Ahmad, et al.
Publicado: (2014)

Evaluation of the influence of the C-X-C motif chemokine ligand 12 / C-X-C chemokine receptor 4 axis on canine mammary gland tumor cell migration
por: KUDO, Ayano, et al.
Publicado: (2023)

Partial agonist activity of α(1)-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3
por: Gao, Xianlong, et al.
Publicado: (2018)

Prevention of Chemotherapy-Induced Peripheral Neuropathy by Inhibiting C-X-C Motif Chemokine Receptor 2
por: Cho, Hee Seong, et al.
Publicado: (2023)

Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model
por: MA, TENG, et al.
Publicado: (2015)

Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease
por: Feng, Siqi, et al.
Publicado: (2015)

Diagnostic and prognostic values of C-X-C motif chemokine ligand 3 in patients with colon cancer
por: Ruan, Guo-Tian, et al.
Publicado: (2019)

Systematic Pan-Cancer Analysis Reveals X-C Motif Chemokine Receptor 1 as a Prognostic and Immunological Biomarker
por: Cui, Likun, et al.
Publicado: (2023)

Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer
por: ZENG, HENG, et al.
Publicado: (2014)

Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction
por: Sun, Yutian, et al.
Publicado: (2022)

Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4–Directed Molecular Imaging and Therapy
por: Hartrampf, Philipp E., et al.
Publicado: (2023)

Inducible Costimulator-C-X-C Motif Chemokine Receptor 3 Signaling is Involved in Chronic Obstructive Pulmonary Disease Pathogenesis
por: Li, Dan-Yang, et al.
Publicado: (2022)

Ethanol promoting the upregulation of C-X-C Motif Chemokine Ligand 1（CXCL1） and C-X-C Motif Chemokine Ligand 6（CXCL6） in models of early alcoholic liver disease
por: Jiang, Yao, et al.
Publicado: (2022)

C-X-C receptor 7 agonist acts as a C-X-C motif chemokine ligand 12 inhibitor to ameliorate osteoclastogenesis and bone resorption
por: Nugraha, Alexander Patera, et al.
Publicado: (2022)

New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle
por: Evans, Ann E., et al.
Publicado: (2016)

Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
por: Yumimoto, Kanae, et al.
Publicado: (2019)

MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis
por: Yan, Yali, et al.
Publicado: (2022)

The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling
por: Li, Chunyan, et al.
Publicado: (2015)

Role of Chemokine (C–X–C Motif) Ligand 10 (CXCL10) in Renal Diseases
por: Gao, Jie, et al.
Publicado: (2020)

Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer
por: Wu, Qianmiao, et al.
Publicado: (2022)

Andrographolide attenuates LPS-stimulated up-regulation of C-C and C-X-C motif chemokines in rodent cortex and primary astrocytes
por: Wong, Siew Ying, et al.
Publicado: (2016)

The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors
por: Zhang, Chao, et al.
Publicado: (2017)

Expression of C–C motif chemokines and their receptors in bovine placentomes at spontaneous and induced parturition
por: HIRAYAMA, Hiroki, et al.
Publicado: (2019)

C-X-C Motif Chemokine 3 Promotes the Inflammatory Response of Microglia after Escherichia coli-Induced Meningitis
por: Qu, Xinyi, et al.
Publicado: (2023)

α(1)‐Adrenergic Receptors Function Within Hetero‐Oligomeric Complexes With Atypical Chemokine Receptor 3 and Chemokine (C‐X‐C motif) Receptor 4 in Vascular Smooth Muscle Cells
por: Albee, Lauren J., et al.
Publicado: (2017)

Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α(1)-adrenergic receptors at the heteromeric receptor complex
por: Gao, Xianlong, et al.
Publicado: (2018)

Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell‐Derived Chemokine (C‐C Motif) Ligand 2 and Chemokine (C‐X‐C motif) Ligand 1 Contributes to Neointima Formation
por: Yu, Baoqi, et al.
Publicado: (2016)

C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression
por: Yang, Xiao-Yan, et al.
Publicado: (2019)

C-X-C Motif Chemokine 10 Impairs Autophagy and Autolysosome Formation in Non-alcoholic Steatohepatitis
por: Zhang, Xiang, et al.
Publicado: (2017)

Astrocytic C–X–C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity
por: Perez-Nievas, Beatriz G., et al.
Publicado: (2021)

Collagen content and C-X-C motif chemokine ligand 12 expression in neoplastic breast stroma
por: Ferreira, Cindy Juliane da Silva, et al.
Publicado: (2023)

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19
por: Liu, Lina, et al.
Publicado: (2018)

Clinical Significance of C-X-C Motif Chemokine Receptor 4 and Integrin αvβ6 Expression in Breast Cancer
por: Huang, Hongshan, et al.
Publicado: (2020)

Blockage of C-X-C Motif Chemokine Receptor 2 (CXCR2) Suppressed Uric Acid (UA)-Induced Cardiac Remodeling
por: Xu, Mingxi, et al.
Publicado: (2021)

Elevated signal transducers and activators of transcription 1 correlates with increased C-C motif chemokine ligand 2 and C-X-C motif chemokine 10 levels in peripheral blood of patients with systemic lupus erythematosus
por: Dominguez-Gutierrez, Paul R, et al.
Publicado: (2014)

A‐kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C‐X‐C motif) ligand 1/chemokine (C‐X‐C motif) ligand 2 in acute myeloid leukemia
por: Hao, Xiaohong, et al.
Publicado: (2019)

C-X-C Motif Chemokine 10 Contributes to the Development of Neuropathic Pain by Increasing the Permeability of the Blood–Spinal Cord Barrier
por: Li, Hao-Ling, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dh41v11mlaqkosa356nb3sat3a